Heterogeneity in response to neoadjuvant therapy in HER2-positive breast cancer — impact of HER2 score, hormonal receptor status, and Ki-67 proliferation index

INTRODUCTION: Human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) is a biologically heterogeneous disease, exhibiting varying responses to neoadjuvant therapy. This study aimed to assess the predictive value of the HER2 immunohistochemical (IHC) score, hormone receptor (HR) s...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Heba M. Sami, Mervat M. El Deftar, Marwa N. Abd Al-Hafez, Marwa M. Selim, Heba M. El-Zawahry
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Via Medica 2026-10-01
Schriftenreihe:	Oncology in Clinical Practice
Schlagworte:	HER2-positive breast cancer Ki-67 HER2 score ER PR pathological complete response neoadjuvant therapy
Online-Zugang:	https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/107133
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!